InvestDashboard.com



Sucampo Pharmaceuticals, Inc. (SCMP)



$9.3
52 Week Low
$10.15
2017-04-28 15:03:25 MDT
$17.55
52 Week High

Basic Info

Healthcare
Sector
Drug Manufacturers - Other
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $445,720,000Small Cap (Between $200M and $2B)
Analyst Recommendation:2.3Analysts say: Buy-. (1=Strong Buy, 5=Strong Sell)
Beta: 1.03 Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index.

Fundamentals

ForwardPE: 7.48
5 Yr Est Growth: 14.00%
Yield: 0.00%
PEG-Y Ratio: 0.53
Excellent Growth Value at a Reasonable Price! Company's growth plus yield is greater than or equal to the PE Ratio. PEGY less than 1 is Excellent!

Technicals

% Above 50 DayMA: -3.52%
% Above 200 DayMA: -18.67%
SCMP Performance 52 Weeks: -13.53%
S&P 500 Performance 52 Weeks: 13.50%
Downtrend is still intact: SCMP is below both 50 and 200 day Moving Averages. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
SCMP underperforming S&P 500 by -27.03% the last 52 Weeks.

Profile


More Valuation

Price To Book: 2.45
Great Value. Low Price to Book means better value.
EV to EBITDA: 3.97
Great Value! A low EV to EBITDA ratio is great. Ideally, under 10. Under 17 is okay.

More Info

Field Value Average Comments
% Held By Insiders54.19% 17.28%Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling.
% Held By Institutions50.30% 62.07%Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price?
Short % Of Float32.02% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to Equity1.74 1.08 More Aggressive Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %8.04%-00.18% Profit Margin is better than the average! Good job.
Operating Margin %35.16%-05.28% Operating Margin greater than average percent. Good.
Return on Equity %14.58%-08.79% Return on Equity greater than average percent. Good.
Return on Assets %10.34%-01.29% Return on Assets greater than average percent. Good.
Revenue Per Employee $1,655,107.91 $883,096.70 More than average Revenue Per Employee. This stock (or industry) could be very efficient.
Price to Cash 2.22 5.52 Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio 0.28 2.26 Less than than average CPEGY Ratio. Ideally, a CPEGY should be less than 1 or less than 1.5. CPEGY is the PEG Ratio but incorporating the yield and subtracting Cash Per Share.

Quick Thoughts

PROS:
  1. Excellent PEGY (less than 1): 0.53

  2. Low Forward PE: 7.48

  3. Price to Cash Ratio (2.22) is less than average. Good. Company has more cash as percentage of price than other companies.

  4. Price to Book is under 5: 2.45

  5. Better than average EV/EBITDA: 3.97

  6. Profit Margin is positive: 8.04%

  7. Operating Margin is positively good: 35.16%

  8. Return on Equity is positive: 14.58%

  9. Return on Assets is positive: 10.34%

CONS:
  1. Stock is Below Short Term 50DMA: -3.52%

  2. Stock is Below Long Term 200DMA: -18.67%

  3. Stock underperforming S&P 500 over last 52 weeks: -27.03%

  4. Shorted more than average: 32.02%


Headlines


Stock Chart


InvestDashboard.com SCMP: Sucampo Pharmaceuticals, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.